The Dana-Farber Cancer Institute ASHP Accredited PGY-2 Oncology Pharmacy Residency is designed to provide the resident opportunities to develop clinical expertise and leadership skills in oncology pharmacy practice.
The resident will gain experience in a variety of areas of clinical practice including: inpatient and outpatient adult solid tumor and hematologic malignancies, stem cell transplant, palliative care, pediatric oncology, and investigational drug services. Additional clinical and educational experiences include: weekly topic discussions, grand rounds, oral chemotherapy teach, medication safety, administration, research and academia. Practice sites include Dana-Farber Cancer Institute for ambulatory rotations and Brigham and Women's Hospital for inpatient rotations. Opportunities for elective rotations are also available.
The resident will be trained in the ambulatory infusion areas and is expected to staff one day per week during ambulatory rotations. Residents will also take part in the oral chemotherapy teach service. Projects will be determined according to the resident's interests and departmental needs. The resident will be required to complete at least one research project to be presented at a national meeting. Participation in Pharmacy and Therapeutics Committee activities and continuing education programs are also required. Teaching opportunities at area schools of pharmacy are also available.
Applicants must expect to complete an ASHP accredited PGY-1 pharmacy residency and be licensed in the state of Massachusetts by summer of 2019. Application requirements: Complete PhORCAS application by Monday, Dec 30, 2019.
PPS interviews will be conducted on Sunday, December 8th through Wednesday December 11th. For consideration for an interview, please send a message through the PPS messenger. Priority will be given to candidates who submit interview requests by Friday, November 15th. DFCI will also be meeting candidates on Monday afternoon December 9th during the Residency Showcase from 1-4 pm.
Internal Number: 001
About Dana-Farber Cancer Institute
Since its founding in 1947, Dana-Farber has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research. The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.
The mission of the Dana-Farber Cancer Institute Pharmacy Department is to provide expert pharmaceutical care to our patients as an integral member of the health care team. The Pharmacy Department also provides clinical and technical training to pharmacy students and pharmacy residents.